These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20705367)

  • 1. E-2-[3-(3,4-dichlorophenyl)-1-oxo-2-propenyl]-3-methylquinoxaline-1,4-dioxide: a lead antitubercular agent which alters mitochondrial respiration in rat liver.
    Das U; Das S; Bandy B; Gorecki DK; Dimmock JR
    Eur J Med Chem; 2010 Oct; 45(10):4682-6. PubMed ID: 20705367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A
    Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A; Zarranz B; Aldana I; Monge A
    J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones.
    Ramalingam P; Ganapaty S; Rao ChB
    Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
    Ancizu S; Moreno E; Solano B; Villar R; Burguete A; Torres E; Pérez-Silanes S; Aldana I; Monge A
    Bioorg Med Chem; 2010 Apr; 18(7):2713-9. PubMed ID: 20233660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel quinoxaline-alkynyl derivatives and their anti-Mycobacterium tuberculosis activity.
    Raphoko LA; Lekgau K; Lebepe CM; Leboho TC; Matsebatlela TM; Nxumalo W
    Bioorg Med Chem Lett; 2021 Mar; 35():127784. PubMed ID: 33422606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
    Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.
    Ortega MA; Sainz Y; Montoya ME; López De Ceráin A; Monge A
    Pharmazie; 1999 Jan; 54(1):24-5. PubMed ID: 9987794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.
    Vicente E; Villar R; Burguete A; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3321-6. PubMed ID: 18625764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-(3-Aryl-2-propenoyl)-3-methylquinoxaline-1,4-dioxides: a novel cluster of tumor-specific cytotoxins which reverse multidrug resistance.
    Das U; Pati HN; Panda AK; De Clercq E; Balzarini J; Molnár J; Baráth Z; Ocsovszki I; Kawase M; Zhou L; Sakagami H; Dimmock JR
    Bioorg Med Chem; 2009 Jun; 17(11):3909-15. PubMed ID: 19427790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A; Zarranz B; Aldana I; Monge A
    Eur J Med Chem; 2003 Sep; 38(9):791-800. PubMed ID: 14561478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
    Sainz Y; Montoya ME; Martínez-Crespo FJ; Ortega MA; López de Ceráin A; Monge A
    Arzneimittelforschung; 1999 Jan; 49(1):55-9. PubMed ID: 10028381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.
    Puratchikody A; Natarajan R; Jayapal M; Doble M
    Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antituberculosis activity of some new 2-quinoxalinecarbonitriles.
    Montoya ME; Sainz Y; Ortega MA; Lopez De Cerain A; Monge A
    Farmaco; 1998; 53(8-9):570-3. PubMed ID: 10081819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tubercular activity of novel class of spiropyrrolidine tethered indenoquinoxaline heterocyclic hybrids.
    Arumugam N; Almansour AI; Suresh Kumar R; Ibrahim Alaqeel S; Siva Krishna V; Sriram D
    Bioorg Chem; 2020 Jun; 99():103799. PubMed ID: 32247109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.
    Wang T; Tang Y; Yang Y; An Q; Sang Z; Yang T; Liu P; Zhang T; Deng Y; Luo Y
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2084-2090. PubMed ID: 29748048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.
    Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A
    Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin analogs.
    Manna K; Agrawal YK
    Eur J Med Chem; 2010 Sep; 45(9):3831-9. PubMed ID: 20576327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis.
    Chopra S; Koolpe GA; Tambo-Ong AA; Matsuyama KN; Ryan KJ; Tran TB; Doppalapudi RS; Riccio ES; Iyer LV; Green CE; Wan B; Franzblau SG; Madrid PB
    J Med Chem; 2012 Jul; 55(13):6047-60. PubMed ID: 22691154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.